» Articles » PMID: 39010283

Obesity-associated Factors in Psychiatric Outpatients: A Multicenter Questionnaire Survey

Overview
Specialties Neurology
Pharmacology
Date 2024 Jul 16
PMID 39010283
Authors
Affiliations
Soon will be listed here.
Abstract

The prevalence of obesity is increasing worldwide, resulting in various health issues such as hypertension, dyslipidemia, diabetes mellitus, heart disease, and a lower life expectancy. Importantly, several psychiatric disorders and the use of psychotropic medications have been linked to obesity, and the possible risk factors need further investigation. This study examined the prevalence of obesity and its associated factors using a self-administered questionnaire. Participants were recruited from three outpatient clinics and individuals who met one or more of the ICD-10 F0-F9, G4 diagnoses were included. In total, 1384 participants completed the questionnaire about their lifestyle. Statistical analysis compared the demographic and clinical characteristics of the individuals who were obese (Body Mass Index: BMI ≥25) and those who were non-obese (BMI <25). The results revealed that the factors associated with obesity in psychiatric outpatients were being male, prolonged treatment duration, eating out frequently, and use of both second- and first-generation antipsychotics. The study emphasized the importance of closely monitoring BMI in individuals with multiple obesity-related factors.

Citing Articles

Evaluating the Significance of Obesity or Excessive Weight in Various Mental Health Disorders: A Systematic Review.

Falaiye T, Okobi O, Oramu C, Jegede A Cureus. 2025; 17(1):e78251.

PMID: 40027022 PMC: 11871964. DOI: 10.7759/cureus.78251.


Obesity-associated factors in psychiatric outpatients: A multicenter questionnaire survey.

Ishii H, Yamada H, Sato R, Hayashi W, Nakamura D, Sugita S Neuropsychopharmacol Rep. 2024; 44(3):620-630.

PMID: 39010283 PMC: 11544440. DOI: 10.1002/npr2.12465.

References
1.
Grootens K, Meijer A, Hartong E, Doornbos B, Bakker P, Al Hadithy A . Weight changes associated with antiepileptic mood stabilizers in the treatment of bipolar disorder. Eur J Clin Pharmacol. 2018; 74(11):1485-1489. DOI: 10.1007/s00228-018-2517-2. View

2.
Salvi V, Mencacci C, Barone-Adesi F . H1-histamine receptor affinity predicts weight gain with antidepressants. Eur Neuropsychopharmacol. 2016; 26(10):1673-7. DOI: 10.1016/j.euroneuro.2016.08.012. View

3.
Sicras A, Rejas J, Navarro R, Serrat J, Blanca M . Metabolic syndrome in bipolar disorder: a cross-sectional assessment of a Health Management Organization database. Bipolar Disord. 2008; 10(5):607-16. DOI: 10.1111/j.1399-5618.2008.00599.x. View

4.
Mazereel V, Detraux J, Vancampfort D, van Winkel R, De Hert M . Impact of Psychotropic Medication Effects on Obesity and the Metabolic Syndrome in People With Serious Mental Illness. Front Endocrinol (Lausanne). 2020; 11:573479. PMC: 7581736. DOI: 10.3389/fendo.2020.573479. View

5.
Milaneschi Y, Simmons W, van Rossum E, Penninx B . Depression and obesity: evidence of shared biological mechanisms. Mol Psychiatry. 2018; 24(1):18-33. DOI: 10.1038/s41380-018-0017-5. View